ALLISON SLICE: Open Payments
NPI 1801869797 · TIMMONSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 77 payments from 19 companies in 2025. Trend: 2023 $1,130 · 2024 $948 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $227 |
| AstraZeneca Pharmaceuticals LP | 7 | $187 |
| Lilly USA, LLC | 14 | $170 |
| Corcept Therapeutics | 7 | $138 |
| Novo Nordisk Inc | 6 | $112 |
| PFIZER INC. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Amgen Inc. | 3 | $41 |
| Abbott Laboratories | 2 | $39 |
| Dexcom, Inc. | 2 | $36 |
Products named: MOUNJARO, Korlym, VRAYLAR, FARXIGA, AIRSUPRA, UBRELVY, Wegovy, Ozempic.
Industry payments across SC — which companies pay providers there.
